| The role of thrombolytic therapy in the management of paradoxical embolism. | |
| | |
MedLine Citation:
|
PMID: 9705104 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Paradoxical emboli are considered a rare event, representing less than 2% of all arterial emboli. The most common intracardiac defect associated with paradoxical emboli is a patent foramen ovale. Most commonly, a pulmonary embolism is the cause of the acute increase in right atrial pressure leading to a reversal of intracardiac flow and passage of venous embolic material to the left heart. We present a patient with a pulmonary embolism and paradoxical emboli, and discuss therapeutic approach. We suggest that the treatment of choice for the patient with pulmonary embolism and non-limb-threatening acute ischemia due to a paradoxical emboli should be thrombolytic therapy and intracaval filter placement, followed by patent foramen ovale repair. |
| | |
Authors:
|
A d'Audiffret; S S Shenoy; J J Ricotta; M Dryjski |
Related Documents
:
|
10919034 - Experimental studies of new embolizing material for portal vein embolization. 14501234 - Paradoxical arterial emboli causing acute limb ischemia in a patient with essential thr... 9880954 - Arterial embolization of bone metastases: is it worthwhile? 18167024 - In vivo evaluation of a new embolic spherical particle (hepasphere) in a kidney animal ... 458034 - Unexpected giant "v" waves during pulmonary artery catheterization. 12427654 - Coronary artery pattern and outcome of arterial switch operation for transposition of t... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Cardiovascular surgery (London, England) Volume: 6 ISSN: 0967-2109 ISO Abbreviation: Cardiovasc Surg Publication Date: 1998 Jun |
Date Detail:
|
Created Date: 1998-10-07 Completed Date: 1998-10-07 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9308765 Medline TA: Cardiovasc Surg Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 302-6 Citation Subset: IM |
Affiliation:
|
Department of Surgery, SUNY at Buffalo, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angiography Embolism, Paradoxical / drug therapy* Female Heart Septal Defects, Atrial / surgery Humans Ischemia / etiology Leg / blood supply Plasminogen Activators / therapeutic use* Pulmonary Embolism / drug therapy* Thrombolytic Therapy* Thrombosis / complications, drug therapy Urokinase-Type Plasminogen Activator / therapeutic use* Vena Cava Filters |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Changes in the morphology and components of the coronary arteries during the progression of coronary...
Next Document: Late pseudoaneurysm formation after repair of the descending aorta.